Calcium supplements and the heart: a signal that never fully resolved

Whether calcium supplements are bad for the heart has no clean answer, and pretending otherwise misreads the evidence. Two influential meta-analyses in 2010 and 2011 found that calcium pills raised the risk of heart attack by roughly a quarter, while a larger review in 2016 — funded by the National Osteoporosis Foundation — concluded that calcium intake within recommended limits carries no cardiovascular risk in healthy adults [s1][s2][s3]. The disagreement, and who produced which finding, is the useful thing to understand.

The signal: two meta-analyses that unsettled a routine pill

For years calcium supplements were recommended almost reflexively for bone health, especially in older women. That changed in 2010, when a patient-level meta-analysis in the BMJ pooled randomised, placebo-controlled trials of calcium (at least 500 mg a day) in people whose mean age was over 40 [s1]. Across the five trials that supplied individual data — 8,151 participants, median follow-up 3.6 years — 143 people taking calcium had a heart attack against 111 on placebo, a hazard ratio of 1.31 (95 percent confidence interval 1.02 to 1.67; p=0.035) [s1]. The other outcomes moved the same way without reaching significance: stroke 1.20 (0.96 to 1.50), the composite of heart attack, stroke or sudden death 1.18 (1.00 to 1.39), and death from any cause 1.09 (0.96 to 1.23) [s1]. A parallel analysis of trial-level data from 11 studies and 11,921 participants gave a matching pooled relative risk for heart attack of 1.27 (1.01 to 1.59; p=0.038) [s1].

The authors' framing mattered: because calcium supplements are so widely used, they wrote, even a modest increase in risk could translate into a large burden of disease, and the role of the pills in managing osteoporosis warranted reassessment [s1].

The reanalysis: vitamin D didn't rescue it

The obvious objection was that most calcium is taken with vitamin D, which the 2010 analysis had largely excluded. The same group answered it in 2011 by reanalysing the Women's Health Initiative Calcium/Vitamin D study, a seven-year trial of 1 g of calcium plus 400 IU of vitamin D daily in 36,282 postmenopausal women [s2]. The trick was that nearly half the women were already taking their own calcium supplements at randomisation, which masked any effect. Among the 16,718 women (46 percent) who were not, adding calcium and vitamin D raised cardiovascular event rates, with hazard ratios ranging from 1.13 to 1.22 [s2]. Folding those data into a meta-analysis of eight trials plus the WHI participants — 28,072 people, 1,384 heart attacks or strokes — calcium with or without vitamin D increased heart attack risk (relative risk 1.24, 1.07 to 1.45; p=0.004) and the composite of heart attack or stroke (1.15, 1.03 to 1.27; p=0.009) [s2]. A narrower meta-analysis limited to three placebo-controlled trials of calcium plus vitamin D pointed the same way, raising heart attack (relative risk 1.21, 1.01 to 1.44; p=0.04), stroke (1.20, 1.00 to 1.43; p=0.05) and the two combined (1.16, 1.02 to 1.32; p=0.02) [s2]. The conclusion again called for reassessing calcium's role in osteoporosis [s2].

The rebuttal, and who paid for it

The counterweight arrived in 2016, when a systematic review in the Annals of Internal Medicine reached the opposite verdict [s3]. It pooled four randomised trials, judged at low risk of bias, with 27 observational studies at moderate risk [s3]. The trials found no statistically significant difference in cardiovascular events or mortality between people given calcium, or calcium plus vitamin D, and those given placebo, and the cohort studies showed no consistent dose-response relationship [s3]. Its bottom line: calcium intake within the tolerable upper limits of 2,000 to 2,500 mg a day "is not associated with" cardiovascular risk in generally healthy adults [s3].

That is a genuine, well-conducted review — but its primary funding source was the National Osteoporosis Foundation, a body whose remit is promoting calcium and bone health [s3]. That does not make the finding wrong; it is exactly the kind of provenance a reader deserves to weigh, because the reassuring answer to "are my calcium pills safe?" came in part from an organisation with an interest in the answer.

How to read this

The evidence here is genuinely mixed rather than settled, and honest reporting says so. Randomised-trial meta-analyses found a modest but consistent increase in heart-attack risk with supplements [s1][s2]; a later review bounded by recommended intakes found none [s3]. What both camps agree on is a quieter point: calcium from food behaves differently from a concentrated pill, and the case for dietary calcium is far less contested — the theme of our look at dairy, calcium and bone fracture. The episode also rhymes with other supplements sold on a nutrient the body needs but that fail or backfire as pills, from vitamin D in healthy adults to magnesium and selenium. For the bone-density question that started all this, see osteoporosis screening. This article is informational and is not medical advice.